Medicare Part D prescribing changes of tricyclic antidepressants between 2013 and 2014
Date
2017-04-11
Authors
Contributor
Advisor
Department
Instructor
Depositor
Speaker
Researcher
Consultant
Interviewer
Narrator
Transcriber
Annotator
Journal Title
Journal ISSN
Volume Title
Publisher
Volume
Number/Issue
Starting Page
Ending Page
Alternative Title
Abstract
Tricyclic antidepressants were the primary pharmacologic treatment for depression in the United States from the 1960s to the late 1980s. Since then, other classes of antidepressants, such as Selective Serotonin Reuptake Inhibitors, have replaced its use as first-line agents due to their more favorable side-effect profile and proven equal efficacy. Tricyclic antidepressants are included in the Beers Criteria because of their potentially harmful side effects in the elderly (e.g. cognitive impairment, delirium, sedation, and orthostatic hypotension). The purpose of this study is to evaluate the changes in prescribing
of tricyclic antidepressants from 2013 to 2014 in Medicare beneficiaries.
Description
Pdf
Keywords
Antidepressive Agents, Tricyclic, Medicare Part D, Inappropriate Prescribing, Physicians' practice patterns
Citation
Extent
1 poster
Format
Geographic Location
Time Period
Related To
Related To (URI)
Table of Contents
Rights
This item is licensed under a Creative Commons License.
Rights Holder
Local Contexts
Collections
Email libraryada-l@lists.hawaii.edu if you need this content in ADA-compliant format.